Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.28
-0.88 (-4.16%)
At close: Dec 5, 2025, 4:00 PM EST
20.26
-0.02 (-0.10%)
After-hours: Dec 5, 2025, 5:01 PM EST
Neurogene Market Cap
Neurogene has a market cap or net worth of $314.13 million as of December 5, 2025. Its market cap has increased by 22.95% in one year.
Market Cap
314.13M
Enterprise Value
58.93M
1-Year Change
22.95%
Ranking
Category
Stock Price
$20.28
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $314.13M, an increase of 62.23%. That is a compound annual growth rate of 27.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 314.13M | -7.49% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |